![PDF) Olaparib treatment in older patients with ovarian cancer: need for 'real-world' data beyond clinical trials PDF) Olaparib treatment in older patients with ovarian cancer: need for 'real-world' data beyond clinical trials](https://i1.rgstatic.net/publication/344250532_Olaparib_treatment_in_older_patients_with_ovarian_cancer_need_for_'real-world'_data_beyond_clinical_trials/links/5f60aa2692851c0789679ea6/largepreview.png)
PDF) Olaparib treatment in older patients with ovarian cancer: need for 'real-world' data beyond clinical trials
![Gabor Liposits в Twitter: "ESMO's official decision support system the ONCOassist app included G8 screening tool. Important step forward getting more recognition for #gerionc. Get it today! It is free! @YoungSIOG @SIOGorg @ Gabor Liposits в Twitter: "ESMO's official decision support system the ONCOassist app included G8 screening tool. Important step forward getting more recognition for #gerionc. Get it today! It is free! @YoungSIOG @SIOGorg @](https://pbs.twimg.com/media/DwDQ0GJWkAAGDe9.jpg)
Gabor Liposits в Twitter: "ESMO's official decision support system the ONCOassist app included G8 screening tool. Important step forward getting more recognition for #gerionc. Get it today! It is free! @YoungSIOG @SIOGorg @
Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients wit
![Fabio GOMES | Clinical Research Fellow | MD MRes | The Christie NHS Foundation Trust, Manchester | Medical Oncology Fabio GOMES | Clinical Research Fellow | MD MRes | The Christie NHS Foundation Trust, Manchester | Medical Oncology](https://i1.rgstatic.net/ii/profile.image/899362599231489-1591436161724_Q512/Fabio_Gomes11.jpg)
Fabio GOMES | Clinical Research Fellow | MD MRes | The Christie NHS Foundation Trust, Manchester | Medical Oncology
![Nicolò BATTISTI | Clinical Research Fellow in Medical Oncology - Specialty Doctor | The Royal Marsden NHS Foundation Trust, London | Department of Medicine - Breast Unit Nicolò BATTISTI | Clinical Research Fellow in Medical Oncology - Specialty Doctor | The Royal Marsden NHS Foundation Trust, London | Department of Medicine - Breast Unit](https://i1.rgstatic.net/ii/profile.image/813203269353472-1570894176479_Q512/Nicolo_Battisti.jpg)
Nicolò BATTISTI | Clinical Research Fellow in Medical Oncology - Specialty Doctor | The Royal Marsden NHS Foundation Trust, London | Department of Medicine - Breast Unit
![PDF) Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper PDF) Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper](https://i1.rgstatic.net/publication/329095838_Use_of_cyclin-dependent_kinase_46_CDK46_inhibitors_in_older_patients_with_ER-positive_HER2-negative_breast_cancer_Young_International_Society_of_Geriatric_Oncology_review_paper/links/5bf5745b4585150b2bc8ac62/largepreview.png)
PDF) Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper
![PDF) 3-D Conformal Photon Boost in the Treatment of Early Stage Breast Cancer: Four Year Follow Up Results | Ákos Horváth, Gabor Liposits, and Ferenc Lakosi - Academia.edu PDF) 3-D Conformal Photon Boost in the Treatment of Early Stage Breast Cancer: Four Year Follow Up Results | Ákos Horváth, Gabor Liposits, and Ferenc Lakosi - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/42206818/mini_magick20190218-13468-1tsktds.png?1550479188)